virus

(redirected from HTLV-II)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
Related to HTLV-II: HTLV1
See: disease
References in periodicals archive ?
De igual forma se hizo la reconfirmacion de la infeccion por HTLV-II empleando cebadores especificos del gen en la envoltura (43).
The antibody-positive samples were obtained from five persons infected with HTLV-I and II infected with HTLV-II. CDC previously had determined the Htlv-I/II-antibody reactivity of these samples through composite testing by using enzyme immunoassay (EIA) kits licensed by the Food and Drug Administration (FDA) and by Western blot (WB) and radioimmunoprecipitation assay (RIPA) antibody tests using the interpretive criteria of the Public Health Service Working Group (1 ).
"The identification of HTLV-II in drug abusers in this country raises the possibiliby that it might cause disease.
HTLV-II has also been associated with HTLV-associated myelopathy, but not with leukemia (5).
During December 1989--March 1990, Guaymi households were randomly selected and contacted for a cross-sectional study to determine risk factors for HTLV-II infection.
No cross-reactivity was observed between RAV-0 p27 gag protein and antibodies against HIV-1, HIV-2, HTLV-I, and HTLV-II (data not shown).
Human T-lymphotropic virus type II (HTLV-II), the second human retrovirus discovered, is closely related to HTLV-I and is presumably transmitted via the same mechanisms.
The previously described HTLV viruses include the AIDS virus (HIV-1), as well as HTLV-I and HTLV-II, which apparently can cause some leukemias and lymphomas.
Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection.
The factors, which cause new blood vessel growth and support longterm cultures of sarcoma cells, were produced in vitro by lymphocytes infected with HTLV-II, a retrovirus that does not cause AIDS.
Infeccao pelos virus linfotropicos de celulas T humanas dos tipos I (HTLV-I) e II (HTLV-II) em portadores de HIV em Santos--Sao Paulo: estudo de prevalencia e fatores de risco.